A Double-Blind, Randomized, Placebo-Controlled, Phase II Clinical Study To Evaluate the Efficacy and Safety of Camostat Mesylate (DWJ1248) in Adult Patients with Mild to Moderate COVID-19

Although several antiviral agents have become available for coronavirus disease 2019 (COVID-19) treatment, oral drugs are still limited. Camostat mesylate, an orally bioavailable serine protease inhibitor, has been used to treat chronic pancreatitis in South Korea, and it has an in vitro inhibitory...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Yeon-Sook, Jeon, Seng-Ho, Kim, Junghee, Koh, Jong Hoon, Ra, Seung Won, Kim, Ji Won, Kim, Yeonjae, Kim, Choon Kwan, Shin, Yun Chul, Kang, Beo Deul, Kang, Seung ji, Park, Chul Hee, Lee, Boyoung, Lee, Ji Yeon, Lee, Chung Hoon, Choi, Jae-phil, Kim, Jin Yong, Yu, Shi Nae, Peck, Kyong Ran, Kim, Sung-Han, Heo, Jung Yeon, Kim, Hyun ah, Park, Hyun-jin, Choi, Jongwon, Han, Jumi, Kim, JooHyun, Kim, Hyoung jun, Han, Se Hee, Yoon, Aeri, Park, MiHee, Park, SuJung, Kim, YuKyung, Jung, Minji, Oh, Myoung-don
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2022
Materias:
Antiviral Agents
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9872678/
https://www.ncbi.nlm.nih.gov/pubmed/36515544
http://dx.doi.org/10.1128/aac.00452-22

Ejemplares similares

Ejemplares similares